GT200800126A - Enmascaramiento del sabor de polvos - Google Patents

Enmascaramiento del sabor de polvos

Info

Publication number
GT200800126A
GT200800126A GT200800126A GT200800126A GT200800126A GT 200800126 A GT200800126 A GT 200800126A GT 200800126 A GT200800126 A GT 200800126A GT 200800126 A GT200800126 A GT 200800126A GT 200800126 A GT200800126 A GT 200800126A
Authority
GT
Guatemala
Prior art keywords
flavor mask
dust
dust flavor
mask
administration
Prior art date
Application number
GT200800126A
Other languages
English (en)
Spanish (es)
Inventor
Bellinghausen Rainer
Rudhardt Daniel
Ridder Frank
Steinbeck Martin
Zank Jesko
Weiss Martin
Behrend Olaf
Van Stiphout Udo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200800126A publication Critical patent/GT200800126A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Seasonings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GT200800126A 2005-12-24 2008-06-23 Enmascaramiento del sabor de polvos GT200800126A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005062270A DE102005062270A1 (de) 2005-12-24 2005-12-24 Geschmacksmaskierung von Pulvern

Publications (1)

Publication Number Publication Date
GT200800126A true GT200800126A (es) 2010-06-25

Family

ID=38042692

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200800126A GT200800126A (es) 2005-12-24 2008-06-23 Enmascaramiento del sabor de polvos

Country Status (24)

Country Link
US (1) US20090269411A1 (enExample)
EP (1) EP1968555A2 (enExample)
JP (2) JP5275039B2 (enExample)
KR (2) KR20080081021A (enExample)
CN (1) CN101346133A (enExample)
AU (1) AU2006331009B2 (enExample)
BR (1) BRPI0620618A2 (enExample)
CA (1) CA2634481A1 (enExample)
CR (1) CR10112A (enExample)
CU (1) CU23877B1 (enExample)
DE (1) DE102005062270A1 (enExample)
EC (1) ECSP088577A (enExample)
GT (1) GT200800126A (enExample)
HN (1) HN2008000964A (enExample)
IL (1) IL192085A0 (enExample)
MA (1) MA30072B1 (enExample)
MY (1) MY149601A (enExample)
NZ (1) NZ569279A (enExample)
RU (1) RU2440103C2 (enExample)
SV (1) SV2009002971A (enExample)
TN (1) TNSN08284A1 (enExample)
UA (1) UA93072C2 (enExample)
WO (1) WO2007073911A2 (enExample)
ZA (1) ZA200805498B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0327723D0 (en) 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
EP2050437A1 (en) * 2007-10-15 2009-04-22 Laboratoires SMB Improved pharmaceutical dry powder compositions for inhalation.
CA2714598A1 (en) * 2008-02-13 2009-08-20 Bayer Schering Pharma Aktiengesellschaft Drug delivery system with stabilising effect
US20110097405A1 (en) * 2008-02-13 2011-04-28 Bayer Schering Pharma Aktiengesellschaft Estradiol-containing drug delivery system
NZ593217A (en) * 2008-12-05 2013-05-31 Bayer Ip Gmbh Extrudate having spicular active substances
EP2411137B1 (en) 2009-03-27 2016-09-07 Bend Research, Inc. Spray-drying process
UY32836A (es) 2009-08-12 2011-03-31 Bayer Schering Pharma Ag Partículas estabilizadas que comprenden 5-metil-(6s)-tetrahidrofolato
EP2467126A1 (en) 2009-08-19 2012-06-27 Bayer Pharma Aktiengesellschaft Drug delivery systems (wafer) for pediatric use
US9084944B2 (en) 2010-09-03 2015-07-21 Bend Research, Inc. Spray-drying apparatus and methods of using the same
US8815294B2 (en) 2010-09-03 2014-08-26 Bend Research, Inc. Pharmaceutical compositions of dextran polymer derivatives and a carrier material
PT2611529T (pt) 2010-09-03 2019-05-09 Bend Res Inc Método de secagem por pulverização
KR101869114B1 (ko) 2010-09-20 2018-06-19 다이앤 골 마이크로캡슐화 방법 및 제품
WO2012040502A1 (en) 2010-09-24 2012-03-29 Bend Research, Inc. High-temperature spray drying process and apparatus
HU231017B1 (hu) 2012-05-08 2019-11-28 LAVET Gyógyszeripari Kft. Praziquantel tartalmú ízfedett formulációk
US8993041B2 (en) * 2012-10-15 2015-03-31 New Jersey Institute Of Technology Taste masked active pharmaceutical powder compositions and processes for making them
US11364203B2 (en) 2014-10-31 2022-06-21 Bend Reserch, Inc. Process for forming active domains dispersed in a matrix
CN114993892B (zh) * 2019-05-13 2024-10-18 南京制药厂有限公司 吡喹酮粒度的光散射检测法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4568559A (en) * 1984-02-06 1986-02-04 Biotek, Inc. Composite core coated microparticles and process of preparing same
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
CA2328080C (en) * 1998-04-09 2008-08-12 Eurand International S.P.A. Wettable microcapsules having hydrophobic polymer coated cores
FR2811913B1 (fr) * 2000-07-19 2003-09-19 Separex Sa Procede d'encapsulation sous forme de micro-capsules de fines particules solides
GB2405798A (en) * 2003-09-15 2005-03-16 Vectura Ltd Dry powder inhaler with primary and secondary piercing elements and a medicament pack for use with an inhalation device.

Also Published As

Publication number Publication date
UA93072C2 (ru) 2011-01-10
AU2006331009A1 (en) 2007-07-05
DE102005062270A1 (de) 2007-06-28
CU23877B1 (es) 2013-04-19
JP2013144695A (ja) 2013-07-25
JP5275039B2 (ja) 2013-08-28
KR20080081021A (ko) 2008-09-05
RU2440103C2 (ru) 2012-01-20
JP2009521419A (ja) 2009-06-04
MY149601A (en) 2013-09-13
SV2009002971A (es) 2009-04-28
BRPI0620618A2 (pt) 2011-11-16
AU2006331009B2 (en) 2012-10-04
KR101245627B1 (ko) 2013-03-20
US20090269411A1 (en) 2009-10-29
CA2634481A1 (en) 2007-07-05
ECSP088577A (es) 2008-07-30
CR10112A (es) 2009-01-07
EP1968555A2 (de) 2008-09-17
TNSN08284A1 (en) 2009-10-30
NZ569279A (en) 2011-06-30
CN101346133A (zh) 2009-01-14
WO2007073911A2 (de) 2007-07-05
HN2008000964A (es) 2013-03-11
CU20080124A7 (es) 2010-08-30
KR20120006085A (ko) 2012-01-17
ZA200805498B (en) 2009-11-25
IL192085A0 (en) 2008-12-29
RU2008130171A (ru) 2010-01-27
WO2007073911A3 (de) 2007-08-23
MA30072B1 (fr) 2008-12-01

Similar Documents

Publication Publication Date Title
GT200800126A (es) Enmascaramiento del sabor de polvos
MXPA03008398A (es) Formulaciones de polvos para inhalacion.
TW200716206A (en) Unitary pharmaceutical dosage form
BRPI0806531A2 (pt) Composto, composição farmacêutica, agente terapêutico, e, uso do composto.
BRPI0710508B8 (pt) composição de pepticorpo terapêutico liofilizado estável, kit para preparar uma composição farmacêutica aquosa, e métodos para fabricar um pepticorpo terapêutico liofilizado e para preparar uma composição de pepticorpo terapêutico reconstituído
WO2006096434A3 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
CL2004001069A1 (es) Compuestos derivados de 1-benzoil-isoquinolinas sustituidos; procedimiento de preparacion, composicion farmaceutica; y uso para el tratamiento o profilaxis de diabetes tipo ii.
IL221103A0 (en) Inhaler powdered, particularly medical substances
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
EP2143724A4 (en) NUCLEOUS FUSED CYBLE DERIVATIVE, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF FOR MEDICAL USES
ITMI20031570A1 (it) Composizione per uso dietetico, farmaceutico o cosmetico
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
CL2007001838A1 (es) Compuestos derivados de 4-oxoquinolina; composicion farmaceutica; y uso del compuesto para la produccion de un agente anti-vih.
MX2010005036A (es) Formulaciones de polvo seco que comprenden derivados del acido ascorbico.
WO2006096444A3 (en) Chemical compounds
ITRM20030363A1 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico di esse.
NO20044497L (no) Torr pulver sammensetninger
WO2008004100A9 (en) Therapeutic compounds
WO2005041922A3 (en) Composition
HN2003000104A (es) Derivados de ciclopenteno
DK1567139T3 (da) Hidtil ukendt synergistisk kombination der omfatter roflumilast og formoterol
GEP20115158B (en) Use of ivabradine for obtaining medicaments intended for the treatment of endothelial dysfunction
CY1106013T1 (el) Ρινικη φαρμακευτικη συνθεση της πepιβεδιλης
BRPI0820659A2 (pt) composto, prodroga de composto, composição farmacêutica e formulação oral e uso de composto.
WO2007086911A3 (en) Stable nanoparticle formulations